ALDX Logo

Aldeyra Therapeutics, Inc. (ALDX) 

NASDAQ$6.985+0.18 (2.64%)
Market Cap
$406.62M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
90 of 924
Rank in Industry
67 of 527

ALDX Insider Trading Activity

ALDX Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$2,768,372571
Sells
$127,288229

Related Transactions

PERCEPTIVE ADVISORS LLC10 percent owner5$2.77M0$0$2.77M
Greenberg BruceSee Remarks0$01$51,313$-51,313
Machatha StephenChief Development Officer0$01$75,975$-75,975

About Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical trial for psoriasis, asthma, and COVID-19; and ADX-2191, a dihydrofolate reductase inhibitor which is in â€¦

Insider Activity of Aldeyra Therapeutics, Inc.

Over the last 12 months, insiders at Aldeyra Therapeutics, Inc. have bought $2.77M and sold $127,288 worth of Aldeyra Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Aldeyra Therapeutics, Inc. have bought $12.32M and sold $2.65M worth of stock each year.

Highest buying activity among insiders over the last 12 months: PERCEPTIVE ADVISORS LLC (10 percent owner) — $2.77M.

The last purchase of 37,712 shares for transaction amount of $178,755 was made by PERCEPTIVE ADVISORS LLC (10 percent owner) on 2024‑04‑05.

List of Insider Buy and Sell Transactions, Aldeyra Therapeutics, Inc.

2024-08-12SaleMachatha StephenChief Development Officer
16,041
0.0272%
$4.74$75,975+12.53%
2024-08-12SaleGreenberg BruceSee Remarks
10,834
0.0184%
$4.74$51,313+12.53%
2024-04-05PurchasePERCEPTIVE ADVISORS LLC10 percent owner
37,712
0.0643%
$4.74$178,755+4.98%
2024-04-04PurchasePERCEPTIVE ADVISORS LLC10 percent owner
140,281
0.2374%
$4.67$655,112+5.77%
2024-04-03PurchasePERCEPTIVE ADVISORS LLC10 percent owner
309,847
0.5185%
$4.09$1.27M+19.16%
2024-04-02PurchasePERCEPTIVE ADVISORS LLC10 percent owner
186,051
0.3061%
$3.44$640,015+39.15%
2024-04-01PurchasePERCEPTIVE ADVISORS LLC10 percent owner
8,374
0.0141%
$3.25$27,216+51.07%
2024-03-12SaleBrady Todd CPresident and CEO
85,324
0.147%
$3.05$260,238+62.13%
2024-03-12SaleMachatha StephenChief Development Officer
11,537
0.0206%
$3.16$36,503+62.13%
2024-03-11SaleBrady Todd CPresident and CEO
97,914
0.1675%
$3.27$320,521+49.85%
2024-03-11SaleMachatha StephenChief Development Officer
18,231
0.0324%
$3.41$62,102+49.85%
2024-03-11SaleGreenberg BruceSee Remarks
13,201
0.0235%
$3.41$44,968+49.85%
2023-10-18SalePERCEPTIVE ADVISORS LLC10 percent owner
306,499
0.5276%
$1.74$533,308+112.14%
2023-10-16SalePERCEPTIVE ADVISORS LLC10 percent owner
2.45M
3.6657%
$1.60$3.92M+98.63%
2023-04-12PurchaseMiller-Rich Nancydirector
509
0.0009%
$10.13$5,156-45.04%
2022-08-09PurchaseEDELMAN JOSEPH
15,000
0.027%
$7.85$117,750-4.83%
2022-08-08PurchaseEDELMAN JOSEPH
97,000
0.1669%
$7.24$702,280-1.53%
2022-08-05PurchaseEDELMAN JOSEPH
141,000
0.2422%
$6.95$979,950+2.46%
2022-08-04PurchaseEDELMAN JOSEPH
95,100
0.1609%
$6.17$586,767+13.62%
2022-08-03PurchaseEDELMAN JOSEPH
100,000
0.1722%
$5.84$584,000+21.90%
Total: 73
*Gray background shows transactions not older than one year

Insider Historical Profitability

17.71%
PERCEPTIVE ADVISORS LLC10 percent owner
9275851
15.5352%
$63.17M182+4.56%
EDELMAN JOSEPH
11350085
19.0091%
$77.29M90+19.39%
Brady Todd CPresident and CEO
1471298
2.4641%
$10.02M112+8.57%
DOUGLAS RICHARDdirector
125000
0.2093%
$851,250.0070+43%
Reed JoshuaChief Financial Officer
35774
0.0599%
$243,620.9410+5.74%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

Aldeyra Therapeutics, Inc.
(ALDX)
$84,871,118
57
17.71%
$406.62M
$24,384,691
42
-30.27%
$400.47M
$26,923,982
20
-17.22%
$415.61M
$73,222,926
18
60.19%
$406.77M
$100,566,697
18
-5.10%
$466.15M

ALDX Institutional Investors: Active Positions

Increased Positions65+57.52%4M+11.49%
Decreased Positions41-36.28%3M-8.53%
New Positions24New2MNew
Sold Out Positions18Sold Out1MSold Out
Total Postitions137+21.24%38M+2.96%

ALDX Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Perceptive Advisors Llc$47,400.0015.46%9.28M00%2024-12-31
Knoll Capital Management, Llc$27,980.009.13%5.48M00%2024-12-31
Blackrock, Inc.$19,368.006.32%3.79M+55,782+1.49%2024-12-31
Vanguard Group Inc$19,197.006.26%3.76M-3,831-0.1%2024-12-31
Kennedy Capital Management Llc$7,504.002.45%1.47M-412,559-21.93%2024-12-31
Ardsley Advisory Partners Lp$5,877.001.92%1.15M+650,000+130%2024-12-31
Geode Capital Management, Llc$5,721.001.87%1.12M+4,927+0.44%2024-12-31
State Street Corp$5,281.001.72%1.03M+59,465+6.11%2024-12-31
Dimensional Fund Advisors Lp$3,760.001.23%735,763+131,722+21.81%2024-12-31
Raymond James Financial Inc$3,716.001.21%727,118+727,118New2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
1.75SellsBuysStrong BuyBuyHoldSellStrong SellALDXHighAverageLowSeries 4